Biologic and Glucocorticoid Use after Methotrexate Initiation in Patients with Rheumatoid Arthritis.

CONCLUSION: Biologic therapy is initiated less frequently in patients with RA who are older, have more comorbidities, and who are nonwhite. While biologics may be avoided in older and sicker patients because of safety concerns, glucocorticoid use is similar regardless of age and is more frequent in patients with comorbidities, with implications for patient outcomes. PMID: 30275262 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30275262?dopt=Abstract

Source: J Rheumatol - October 1, 2018 Category: Rheumatology Authors: George MD, Sauer BC, Teng CC, Cannon GW, England BR, Kerr GS, Mikuls TR, Baker JF Tags: J Rheumatol Source Type: research